share_log

Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.

Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.

kura oncology的股票在下跌。該公司宣佈與昌榮製藥達成全球貨幣戰略合作,共同開發和商業化Ziftomenib。
Benzinga ·  11/21 10:53

Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.

Kura Oncology 股價走低。該公司宣佈與協和麒麟達成全球戰略合作,以開發和商業化Ziftomenib。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論